Longevity & AgingArticolo di ricercaA pagamento

Sensory nerves send the growth signals that tell broken bones to heal

A Science study maps the sensory neurons wired into bone and finds FGF9, a nerve-derived signal, is a major driver of fracture repair in mice.

martedì 3 novembre 2026 1 visualizzazione
Pubblicato in Science
Glowing sensory nerve fibers branching into a fractured bone, releasing FGF9 molecules toward green-lit progenitor cells at the break

Riepilogo

Fracture pain travels through sensory nerves, and those same nerves appear to help start bone regeneration. Researchers used single-cell RNA sequencing to profile dorsal root ganglion neurons that innervate mouse bone, before and after a fracture. CGRP+ peptidergic neurons and Aβ-Field low-threshold mechanoreceptors were the most common bone-innervating types. After injury, these neurons shifted their gene expression in step with the phases of bone repair, turning on morphogens including Tgfb1, Fgf9, and Shh. Removing bone innervation impaired healing and was linked to poor proliferation and osteogenic differentiation of mesenchymal cells. The team then identified fibroblast growth factor 9 (FGF9) as a major regulator of fracture repair that might be harnessed therapeutically. The findings are preclinical, but they point to nerve-derived signals as potential targets for improving bone healing.

0:00--:--

Riepilogo Dettagliato

Bone fractures hurt, and that pain is carried by somatosensory neurons. Evidence has also suggested that these nerves are needed to start bone regeneration. Which neurons innervate bone, and what they release to support repair, has been poorly defined. This matters for aging populations, where slow or failed fracture healing drives disability and mortality.

The researchers used single-cell transcriptomics to profile dorsal root ganglion (DRG) neurons that innervate murine bone. They did this before and after fracture, which let them see how the neurons' molecular programs change during injury and repair.

CGRP+ neurons and Aβ-Field low-threshold mechanoreceptors (LTMRs) were the most represented bone-innervating classes. After fracture, the neurons' responses changed dynamically, mirroring the phasic nature of bone repair. They included expression of morphogens such as Tgfb1, Fgf9, and Shh. When innervation was lost, bone repair was poor, with defective mesenchymal cell proliferation and osteodifferentiation. From this work the authors identified fibroblast growth factor 9 (FGF9) as a major regulator of fracture repair that could be leveraged to promote healing.

The work suggests bone healing depends on active communication from sensory nerves to progenitor cells, not only on local bone and immune signaling. It also raises the possibility that FGF9-based or other neurotrophic strategies could help in fractures with impaired healing, such as those in older adults or in people with nerve damage.

Caveats: only the abstract was available, so details on experimental design, dosing, effect sizes, and sex or age of the animals are unknown. The data come from mice, and translation to human fracture care has not been shown. Whether FGF9 can be delivered safely and effectively in people remains untested.

Risultati Principali

  • Single-cell profiling of mouse bone-innervating DRG neurons showed CGRP+ and Aβ-Field LTMR neurons were the most represented classes.
  • Sensory neurons changed gene expression after fracture in a pattern matching the phases of bone repair.
  • Injured bone-innervating neurons expressed morphogens including Tgfb1, Fgf9, and Shh.
  • Loss of bone innervation impaired repair and was linked to defective mesenchymal proliferation and osteodifferentiation.
  • FGF9 emerged as a major regulator of fracture repair that could potentially be leveraged therapeutically.

Metodologia

Researchers used single-cell transcriptomics to profile dorsal root ganglion neurons innervating murine bone before and after fracture. They also tested the effect of innervation loss on bone repair and mesenchymal cell behavior, and evaluated FGF9 as a regulator of healing. Details beyond the abstract were not available.

Limitazioni dello Studio

The analysis is based on the abstract only, and the findings come from mouse models, so human relevance is unproven. Sample sizes, effect magnitudes, and safety or delivery of FGF9 as a therapy are not described. Other nerve-derived signals may also contribute and were not fully characterized in the available text.

Ti è piaciuto questo riepilogo?

Ricevi ogni settimana le ultime ricerche sulla longevità direttamente nella tua casella email.

Inserisci la tua email per iscriverti: